12 reports

2018 Emerging Cancer Diagnostic Technologies and Market Applications This report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/ microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applica

  • Chromosome
  • Genomics
  • Immunochemistry Test
  • In Vitro Diagnostics
  • Demand
  • INBORN GENE OR CHROMOSOME ALTERATIONS - PIPELINE PRODUCTS BY TERRITORY
  • INBORN GENE OR CHROMOSOME ALTERATIONS - ONGOING CLINICAL TRIALS

Inborn Gene or Chromosome Alterations - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Inborn Gene or Chromosome Alterations - Medical Devices Pipeline Assessment, 2016" provides an overview of Inborn Gene or Chromosome Alterations currently in pipeline stage. The...

  • Chromosome
  • Clinical Trial
  • Prostate Cancer
  • United States
  • GlobalData's company
  • 4. Major Chromosomal Aneuploidies and Incidence Rate Analysis
  • 4.3 PATAU SYNDROME

Noninvasive prenatal testing (NIPT) is an advancement in the detection of fetal chromosomal aneuploidies that analyzes cell-free fetal DNA in the blood of a pregnant woman. Since its introduction to clinical practice in 2011, NIPT has quickly spread across the globe. Hundreds of thousands of pregnant women have used these noninvasive prenatal...

  • Chromosome
  • World
  • Ariosa Diagnostics, Inc.
  • Illumina, Inc.
  • Natera, Inc.
  • INBORN GENE OR CHROMOSOME ALTERATIONS - ONGOING CLINICAL TRIALS
  • INBORN GENE OR CHROMOSOME ALTERATIONS - PIPELINE PRODUCTS BY TERRITORY

Inborn Gene or Chromosome Alterations - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Inborn Gene or Chromosome Alterations - Pipeline Review, 2015" provides an overview of genetic tests for Inborn Gene or Chromosome Alterations currently in pipeline stage. The report provides comprehensive...

  • Cancer
  • Chromosome
  • Clinical Trial
  • United States
  • GlobalData's company
  • ACQUIRED GENE OR CHROMOSOME ALTERATIONS - PIPELINE PRODUCTS BY TERRITORY
  • ACQUIRED GENE OR CHROMOSOME ALTERATIONS - PIPELINE PRODUCTS BY TERRITORY

Acquired Gene or Chromosome Alterations - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Acquired Gene or Chromosome Alterations - Pipeline Review, 2015" provides an overview of genetic tests for Acquired Gene or Chromosome Alterations currently in pipeline stage. The report provides...

  • Cancer
  • Chromosome
  • United States
  • Company
  • GlobalData's company
  • Oxford Biodynamics Plc - Pipeline Analysis Overview
  • EPISWITCH THYROID CANCER DIAGNOSTIC TEST

Summary Oxford Biodynamics Plc (Oxford Biodynamics) is a developer of biomarker discovery platform.The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, inflammatory, cardiovascular and neurodegenerative conditions. Its...

  • Biomarker
  • Chromosome
  • Dementia
  • Hospital
  • In Vitro Diagnostic Reagent
  • DIAGNOSTIC TEST - FGFR-TACC - PRODUCT DESCRIPTION
  • COMPANION DIAGNOSTIC ASSAY - EGFR VIII - PRODUCT DESCRIPTION

Summary Qiagen NV (Qiagen) is a provider of molecular testing solutions.The company offers consumable products, instruments and automation systems. The company’s sample technologies help isolate and process DNA, RNA and proteins from samples such as blood and tissue; assay technologies to identify the genetic information...

  • Chromosome
  • Molecular Diagnostic
  • United States
  • World
  • QIAGEN N.V.
  • Oxford Biodynamics Plc - Pipeline Analysis Overview
  • OXFORD BIODYNAMICS LTD PIPELINE PRODUCTS BY DEVELOPMENT STAGE

Summary Oxford Biodynamics Ltd (Oxford Bio) is a health-care service company that discovers and develops biomarker discovery platform. The company’s biomarker discovery platform is used for the detection of aberrant gene expression. It concentrates on research in detection, monitoring and prognosis of major diseases associated...

  • Biomarker
  • Chromosome
  • Dementia
  • Hospital
  • In Vitro Diagnostic Reagent
  • Chromosome 7 Alpha Satellite Probe Aqua Chromosome 7 Alpha Satellite Probe Aqua Product Overview
  • Chromosome 7 Alpha Satellite Probe Aqua - Product Status

Summary Oxford Gene Technology Ltd (OGT) is a biotechnology company that develops biomarkers. The company offers automation products, chromosome-specific arrays, custom arrays, fish probes, gene-focused arrays, genome-wide arrays, NGS products, reagents and consumables and software. It offers services such as targeted sequencing...

  • Cancer
  • Chromosome
  • Lung Cancer
  • Molecular Diagnostic
  • Company

2018 Emerging Cancer Diagnostic Technologies and Strategic Profiles of Leading Suppliers This ##-page report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/ microarrays, chromosome analysis, IT, flow cytometry, biosensors

  • Chromosome
  • Genomics
  • In Vitro Diagnostics
  • Business Expansion & Exit
  • Demand

chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for tumor markers technologies.

  • Biochip
  • Chromosome
  • In Vitro Diagnostics
  • Business Expansion & Exit
  • Company Operations

The agreement provides Dow with rights to Chromatin' s mini-chromosome technology.

  • Chromosome
  • United States
  • Company
  • Corporate Finance
  • Chromatin, Inc.